Cargando…
Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis
BACKGROUND: Opioid prescribing guidelines have significantly decreased overprescribing and post-discharge use after cardiac surgery; however, limited recommendations exist for general thoracic surgery patients, a similarly high-risk population. We examined opioid prescribing and patient-reported use...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323572/ https://www.ncbi.nlm.nih.gov/pubmed/37426143 http://dx.doi.org/10.21037/jtd-22-1621 |
_version_ | 1785068976222502912 |
---|---|
author | Mondoñedo, Jarred R. Brescia, Alexander A. Clark, Melissa J. Chang, Matthew L. Jiang, Shannon He, Chang Welsh, Robert J. Popoff, Andrew M. Kulkarni, Mohan G. Lall, Shelly C. Pratt, Jerry W. Adams, Kumari N. Alnajjar, Raed M. Martin, James R. Gandhi, Divyakant B. Brummett, Chad M. Chang, Andrew C. Lagisetty, Kiran H. |
author_facet | Mondoñedo, Jarred R. Brescia, Alexander A. Clark, Melissa J. Chang, Matthew L. Jiang, Shannon He, Chang Welsh, Robert J. Popoff, Andrew M. Kulkarni, Mohan G. Lall, Shelly C. Pratt, Jerry W. Adams, Kumari N. Alnajjar, Raed M. Martin, James R. Gandhi, Divyakant B. Brummett, Chad M. Chang, Andrew C. Lagisetty, Kiran H. |
author_sort | Mondoñedo, Jarred R. |
collection | PubMed |
description | BACKGROUND: Opioid prescribing guidelines have significantly decreased overprescribing and post-discharge use after cardiac surgery; however, limited recommendations exist for general thoracic surgery patients, a similarly high-risk population. We examined opioid prescribing and patient-reported use to develop evidence-based, opioid prescribing guidelines after lung cancer resection. METHODS: This prospective, statewide, quality improvement study was conducted between January 2020 to March 2021 and included patients undergoing surgical resection of a primary lung cancer across 11 institutions. Patient-reported outcomes at 1-month follow-up were linked with clinical data and Society of Thoracic Surgery (STS) database records to characterize prescribing patterns and post-discharge use. The primary outcome was quantity of opioid used after discharge; secondary outcomes included quantity of opioid prescribed at discharge and patient-reported pain scores. Opioid quantities are reported in number of 5-mg oxycodone tablets (mean ± standard deviation). RESULTS: Of the 602 patients identified, 429 met inclusion criteria. Questionnaire response rate was 65.0%. At discharge, 83.4% of patients were provided a prescription for opioids of mean size 20.5±13.1 pills, while patients reported using 8.2±13.0 pills after discharge (P<0.001), including 43.7% who used none. Those not taking opioids on the calendar day prior to discharge (32.4%) used fewer pills (4.4±8.1 vs. 11.7±14.9, P<0.001). Refill rate was 21.5% for patients provided a prescription at discharge, while 12.5% of patients not prescribed opioids at discharge required a new prescription before follow-up. Pain scores were 2.4±2.5 for incision site and 3.0±2.8 for overall pain (scale 0–10). CONCLUSIONS: Patient-reported post-discharge opioid use, surgical approach, and in-hospital opioid use before discharge should be used to inform prescribing recommendations after lung resection. |
format | Online Article Text |
id | pubmed-10323572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-103235722023-07-07 Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis Mondoñedo, Jarred R. Brescia, Alexander A. Clark, Melissa J. Chang, Matthew L. Jiang, Shannon He, Chang Welsh, Robert J. Popoff, Andrew M. Kulkarni, Mohan G. Lall, Shelly C. Pratt, Jerry W. Adams, Kumari N. Alnajjar, Raed M. Martin, James R. Gandhi, Divyakant B. Brummett, Chad M. Chang, Andrew C. Lagisetty, Kiran H. J Thorac Dis Original Article BACKGROUND: Opioid prescribing guidelines have significantly decreased overprescribing and post-discharge use after cardiac surgery; however, limited recommendations exist for general thoracic surgery patients, a similarly high-risk population. We examined opioid prescribing and patient-reported use to develop evidence-based, opioid prescribing guidelines after lung cancer resection. METHODS: This prospective, statewide, quality improvement study was conducted between January 2020 to March 2021 and included patients undergoing surgical resection of a primary lung cancer across 11 institutions. Patient-reported outcomes at 1-month follow-up were linked with clinical data and Society of Thoracic Surgery (STS) database records to characterize prescribing patterns and post-discharge use. The primary outcome was quantity of opioid used after discharge; secondary outcomes included quantity of opioid prescribed at discharge and patient-reported pain scores. Opioid quantities are reported in number of 5-mg oxycodone tablets (mean ± standard deviation). RESULTS: Of the 602 patients identified, 429 met inclusion criteria. Questionnaire response rate was 65.0%. At discharge, 83.4% of patients were provided a prescription for opioids of mean size 20.5±13.1 pills, while patients reported using 8.2±13.0 pills after discharge (P<0.001), including 43.7% who used none. Those not taking opioids on the calendar day prior to discharge (32.4%) used fewer pills (4.4±8.1 vs. 11.7±14.9, P<0.001). Refill rate was 21.5% for patients provided a prescription at discharge, while 12.5% of patients not prescribed opioids at discharge required a new prescription before follow-up. Pain scores were 2.4±2.5 for incision site and 3.0±2.8 for overall pain (scale 0–10). CONCLUSIONS: Patient-reported post-discharge opioid use, surgical approach, and in-hospital opioid use before discharge should be used to inform prescribing recommendations after lung resection. AME Publishing Company 2023-06-21 2023-06-30 /pmc/articles/PMC10323572/ /pubmed/37426143 http://dx.doi.org/10.21037/jtd-22-1621 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Mondoñedo, Jarred R. Brescia, Alexander A. Clark, Melissa J. Chang, Matthew L. Jiang, Shannon He, Chang Welsh, Robert J. Popoff, Andrew M. Kulkarni, Mohan G. Lall, Shelly C. Pratt, Jerry W. Adams, Kumari N. Alnajjar, Raed M. Martin, James R. Gandhi, Divyakant B. Brummett, Chad M. Chang, Andrew C. Lagisetty, Kiran H. Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis |
title | Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis |
title_full | Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis |
title_fullStr | Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis |
title_full_unstemmed | Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis |
title_short | Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis |
title_sort | evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323572/ https://www.ncbi.nlm.nih.gov/pubmed/37426143 http://dx.doi.org/10.21037/jtd-22-1621 |
work_keys_str_mv | AT mondonedojarredr evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT bresciaalexandera evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT clarkmelissaj evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT changmatthewl evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT jiangshannon evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT hechang evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT welshrobertj evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT popoffandrewm evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT kulkarnimohang evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT lallshellyc evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT prattjerryw evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT adamskumarin evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT alnajjarraedm evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT martinjamesr evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT gandhidivyakantb evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT brummettchadm evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT changandrewc evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis AT lagisettykiranh evidencebasedopioidprescribingguidelinesafterlungresectionaprospectivemulticenteranalysis |